Patrick
Patrick joined EMD Serono because he was excited about the company's innovative cancer targeting platform (SHARC). He began
his career working in a more technology oriented position before moving into oncology to pursue his interests in cancer modeling
and biology.
Patrick is proud of his contributions to the development of a new stable cell line generation process for the production of
manufacture grade CHO clones. While at EMD Serono, he has seen his work on local initiatives have a positive impact on the
work of his colleagues.
Education
University of Amherst. BS, Biology; BA, Classics (2003)
University of Amherst. BS, Biology; BA, Classics (2003)
Northeastern University. MS, Biotechnology: Drug Discovery and Pharmaceutical Sciences (in progress)
Awards
Recipient of various EMD Serono internal recognition programs for project and group work
Recipient of various EMD Serono internal recognition programs for project and group work
PERSONAL VISION
Patrick’s inspiration has come from his family, friends, and colleagues. Since several members of his family have been afflicted by cancer, he has dedicated his career to research and an improved understanding of the disease. As cancer is a disease of deregulations, Patrick finds it a fascinating subject to study from a variety of approaches. This can provide a better understanding of healthy regulation processes within the human body.
Patrick’s inspiration has come from his family, friends, and colleagues. Since several members of his family have been afflicted by cancer, he has dedicated his career to research and an improved understanding of the disease. As cancer is a disease of deregulations, Patrick finds it a fascinating subject to study from a variety of approaches. This can provide a better understanding of healthy regulation processes within the human body.
